Illumina to divest cancer test maker Grail after antitrust battles By Reuters Finances December 18, 2023 [ad_1] © Reuters. FILE PHOTO: An indication on the entrance entrance to the worldwide headquarters of Illumina is pictured in…
Illumina faces record European Union fine over Grail deal next week – report Finances July 5, 2023 [ad_1] Sundry Images/iStock Editorial through Getty Pictures Illumina (NASDAQ:ILMN) faces a document effective from the European Union as early as…
Illumina Stock Falls on GRAIL Acquisition Fail Markets October 18, 2022 [ad_1] Until you may watch your inventory holding decline by 50% with out changing into panic-stricken, you shouldn’t be within…
